Can toxic metals and mycotoxins add to biological stress?

Toxic metals and mycotoxins have biologically overlapping effects, but the claim is best viewed as mechanistically plausible rather than established for typical human co-exposures—particularly in an older adult, in whom physiologic reserve may be limited.

Shared biological pathways

• Oxidative stress: Lead, mercury, cadmium, and related metals increase reactive oxygen species (ROS) and deplete glutathione and other antioxidant defenses. Experimental studies similarly show zearalenone increases ROS in human leukemia and porcine intestinal cells; mycophenolic acid has also increased intracellular and mitochondrial ROS.
• Mitochondrial injury: Metals can damage mitochondrial DNA. Zearalenone reduced mitochondrial membrane potential and promoted cytochrome-c release/apoptosis. ROS and mitochondrial dysfunction can reinforce one another: ROS-associated injury accompanies loss of membrane potential, while impaired electron transport can itself increase ROS.
• Immune signaling: Metals alter cytokine and inflammatory pathways, including interleukins, TNF-α, and interferon-γ. Zearalenone can alter cytokine profiles and immune-cell function, although pro-inflammatory versus immunosuppressive effects vary by model and conditions.

Combined-exposure evidence

• Direct evidence for combined burden is limited but supports the possibility of additivity. In mice, cadmium chloride plus aflatoxin B₁ was classified as additive and accompanied by blood, liver, and kidney toxicity.
• In neuronal cells, metal–mycotoxin interactions ranged from near-additive to synergistic depending on effect level and interaction model. Thus, a shared oxidative pathway is a credible explanation for aggregate stress, but has not been proven to mediate combined toxicity; mitochondrial and immune mediation remain hypotheses.

Bottom line

• Both exposure classes can independently drive oxidative and mitochondrial stress, and concurrent exposure can plausibly add biological burden even from different sources. However, effects are toxicant-, dose-, tissue-, and endpoint-specific, and current evidence does not establish a universal additive effect or its clinical magnitude in humans.